Aspartic protease inhibitors as drug candidates for treating various difficult-to-treat diseases

Author(s):  
Yoshio Hamada ◽  
Yoshiaki Kiso
2009 ◽  
Vol 2009 (11) ◽  
pp. 1707-1719 ◽  
Author(s):  
Martina Zürcher ◽  
Fraser Hof ◽  
Luzi Barandun ◽  
Andri Schütz ◽  
W. Bernd Schweizer ◽  
...  

2001 ◽  
Vol 3 (15) ◽  
pp. 2309-2312 ◽  
Author(s):  
Amy S Ripka ◽  
Kenneth A. Satyshur ◽  
Regine S. Bohacek ◽  
Daniel H. Rich

2008 ◽  
Vol 18 (9) ◽  
pp. 3011-3015 ◽  
Author(s):  
M. Kamran Azim ◽  
Waseem Ahmed ◽  
Ishtiaq A. Khan ◽  
Nosheen A. Rao ◽  
Khalid M. Khan

2000 ◽  
Vol 2 (25) ◽  
pp. 3955-3958 ◽  
Author(s):  
Gian Luca Marcorin ◽  
Tatiana Da Ros ◽  
Sabrina Castellano ◽  
Giorgio Stefancich ◽  
Irena Bonin ◽  
...  

2010 ◽  
Vol 25 (5) ◽  
pp. 673-678 ◽  
Author(s):  
Waseem Ahmed ◽  
Mubeen Rani ◽  
Ishtiaq A. Khan ◽  
Asif Iqbal ◽  
Khalid M. Khan ◽  
...  

2019 ◽  
Vol 24 (3) ◽  
pp. 441-464 ◽  
Author(s):  
Ammara Akhtar ◽  
Waqar Hussain ◽  
Nouman Rasool

The HIV-1 protease plays an essential role in the replication cycle of HIV-1; therefore there is a direct need to develop novel inhibitors of the HIV-1 protease, which can cease the viral replication. The present study targets the discovery of potential inhibitors of HIV-1 protease from a set of phytochemicals. From 2505 phytochemicals, 108 compounds were docked, after screening, with the HIV-1 protease to analyze their inhibitory potential against the protease. DFT analysis was also conducted to study the reactivity of strongly docked compounds. Out of 108 phytochemicals, 38 compounds showed binding affinity greater than the desired threshold. Reactivity of these 38 inhibitors was also high as compared to other compounds, based on the DFT results. These results suggest that the selected 38 phytochemicals are drug candidates and they have the potential to be effectively used against HIV in the future.


Sign in / Sign up

Export Citation Format

Share Document